Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
08/2006
08/23/2006CN1821216A Dimeglumine gadopentetate and its producing method
08/23/2006CN1270821C Load type catalyzer for synthesizing p-aminophenol, preparation method and method of application
08/18/2006CA2535667A1 A process for the preparation of tolterodine
08/17/2006WO2006086374A2 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/17/2006US20060183806 Compositions and methods comprising long-chain, straight-chain 2-amino-3- hydroxyalkanes
08/16/2006EP1690536A2 Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1819989A 2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof
08/16/2006CN1817851A N-substituted-w-amino-1,2,3,4-tetrahydronaphthalene compounds with antifungal activity and their salts
08/16/2006CN1269793C Method for producing 3,3-diarylpropylamines
08/16/2006CN1269569C Catalyst in use for preparing N-(D)-deoxyribose alcoholic group-3,4-dimethylaniline
08/10/2006WO2006082200A1 Method for directly preparing amino-alcohols or alcohols using halogenozinc hydrides
08/10/2006US20060178475 Branched polymers and their conjugates
08/10/2006US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1687253A2 Diphenylamine derivatives
08/09/2006EP1177197B1 Polyamines and their use in therapy
08/09/2006CN1814583A Method for preparing 2-P-octyl-phenenl-2-amino-propanediol hydrochloride
08/08/2006US7087799 Such as 2,2'-methylenebis(4-methyl-6-hydroxymethylphenol) for production of photosensitive polyimides
08/08/2006US7087778 synthesis of a 2-(2,3,4-trihalogenoanilino)propionic acid by treating trihaloaniline or trihalonitrobenzene with a metal catalyst and dehydrating agent; chemical intermediate for levofloxacin
08/08/2006US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/03/2006WO2006080905A1 Norbornane based cycloaliphatic compounds containing methylene amine groups
08/03/2006WO2006023757A3 Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents
08/03/2006WO2005115406A3 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/02/2006EP1685091A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
08/02/2006EP1685090A1 Androgen receptor modulators
08/02/2006EP1496882B1 Tolterodine salts
08/02/2006EP1370591B1 Active non-metallocene pre-catalyst and method for tactic catalytic polymerization of alpha-olefin monomers
08/02/2006EP1358262B1 Resorcinolic derivative for rubber compounds
08/02/2006EP0970935B1 Method of separating optical isomers
08/02/2006CN1813040A Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers
08/02/2006CN1810767A Production process of 2-amino-methyl-1-propanol
08/01/2006US7083862 Dendrimers
07/2006
07/26/2006EP1368299B1 Substituted c-cyclohexylmethylamine derivatives
07/26/2006CN1266115C Preparation method of 2-(2-arylmorpholine-2-yl)-ethanol and intermediate
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/20/2006US20060161016 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof
07/20/2006US20060160805 Thiotungstate analogues and uses thereof
07/20/2006CA2592969A1 New one-step synthesis of useful disubstituted amines
07/19/2006EP1680393A1 Method for the distillative separation of mixtures containing ethyleneamines
07/19/2006CN1805931A Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
07/19/2006CN1805915A Indene derivatives as pharmaceutical agents
07/19/2006CN1803762A Triisopropanolamine synthesis apparatus and method
07/19/2006CN1264828C Nitric ester and nitrate salts of specific drugs
07/19/2006CN1264807C Production of triethanolamine products
07/19/2006CN1264498C Primary intermediates for oxidative coloration of hair
07/18/2006US7078226 Method for producing optically active amines
07/18/2006US7077872 Dyeing keratin fibers using developer ,coupler, oxidizer
07/18/2006CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them
07/18/2006CA2276488C Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent
07/13/2006WO2006074479A1 Process for preparing tolterodine tartrate
07/13/2006WO2006074478A1 Substantially pure tolterodine tartrate and process for preparing thereof
07/13/2006WO2006072785A2 Base stable ionic liquids
07/13/2006US20060155149 Durable coating compositions containing novel aspartic amine compounds
07/13/2006US20060154933 Inhibitors of Cdc25 phosphatases
07/13/2006CA2590556A1 Process for preparing tolterodine tartrate
07/13/2006CA2590555A1 Substantially pure tolterodine tartrate and process for preparing thereof
07/12/2006EP1678122A1 Improved process for the manufacture of citalopram hydrobromide
07/12/2006CN1802355A Aminoalcohol derivatives
07/12/2006CN1800147A Method for improving isopropanolamine synthetic effect
07/12/2006CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives
07/12/2006CN1263728C Oxyalkylene-substituted aminophenol intermediate
07/12/2006CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
07/11/2006US7074930 Amine salts of an integrin receptor antagonist
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them
07/06/2006US20060149058 Cyclization of compounds such as -[Benzyl(2-hydroxyethyl)amino]-2-(3,4-difluorophenyl)but-3-en-2-ol to produce 2-vinyl-2-arylmorpholine derivatives
07/06/2006US20060148893 Chemical compounds
07/06/2006US20060148650 Inhibitor against biosynthesis of abscisic acid
07/05/2006EP1676831A1 N,N-dialkylpolyhydroxyalkylamines
07/05/2006EP1675817A1 Aminoalkanol derivatives
07/05/2006EP1675816A2 Method for separating triethanolamin from a mixture obtainable by ammonia and ethylene oxide reaction
07/05/2006EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
07/04/2006US7071359 Neuropathy improvers containing nitrogenous compounds as the active ingredient
07/04/2006US7071225 Arylaminopropane analogues and their use for the treatment of glaucoma
07/04/2006US7070630 Primary intermediates for oxidative coloration of hair
06/2006
06/29/2006WO2006024784A3 Aminoglycoside analogues, uses thereof for treating microbial diseases and synthesis thereof
06/29/2006US20060142615 Process for preparing ethanolamine with improved colour
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142387 Naphthylamine compounds such as N-(cyclopropylmethyl)-N-(4-nitro-1-naphthyl)-N-propylamine; selective androgen receptor modulators; osteoporosis, muscle wasting, frailty, cardiovascular disease, hormone-dependent cancers, dyslipidemia, menopausal vasomotor conditions, sexual disorders
06/28/2006EP1259243B1 Bupropion metabolites and methods of their synthesis and use
06/28/2006CN1795271A Autoinducer compound to improve the productivity of natamycin producing streptomyces strains
06/28/2006CN1795169A Crystalline form of beta2 adrenergic receptor agonist
06/28/2006CN1793109A Process for synthesizing N,N-dimethyl hydroxyl amine
06/28/2006CN1261406C Process for producing 4,6-diaminoresorcinol or its salts
06/28/2006CN1261405C Optically active amine derivative and method of synthesis
06/22/2006WO2006065214A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
06/22/2006WO2006064283A1 Pharmaceutical compounds and compositions
06/22/2006US20060135579 amino alcohols; selective ribonucleic acid (RNA) binding agents; detecting the binding of small molecules to T-box antiterminator model mRNAs; screening for microbiocidal drug targets; use disinfecting; antiviral, anti-HIV; e.g. use of 1,2-dihydroxy-3-amino-4-phenylbutane
06/22/2006CA2591406A1 Pharmaceutical compounds and compositions
06/22/2006CA2589519A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
06/21/2006EP1671942A1 Aerosol formulation comprising levalbuterol L-tartrate salt
06/20/2006US7064236 such as dimethyl-[phenyl-(2-phenyl-cyclohex-1-enyl)-methyl]-amine for treatment of pain, depression, hypotension, senile dementia, tinnitus, hearing loss, epilepsy, obesity, cachexia, urinary incontinence, anxiolysis, diuresis, and alzheimer's disease
06/15/2006US20060128996 Compositions containing Ionic liquids and uses thereof, especially in organic synthesis
06/14/2006CN1259306C Process for the preparation of aminoalcohol, aminoalcohol derivatives and their further conversion to (1S, 4R)-4-(2-AMINO - 6-CHLORO - 9- H - PURINE - 9-YL)-2- CYCLOPENTENYL-1-METHANOL or its salt
06/13/2006US7060851 Method of preparing retroviral protease inhibitor intermediates
06/13/2006US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant
06/13/2006US7060198 Heat exchange fluids comprising amine carboxylates
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 116